FIELD: internal diseases. SUBSTANCE: biochemical characteristics in body fluids, in particular blood levels of beta-2 microglobulin and fibronectin, are determined and, when beta-2 microglobulin level is > 2.4 mg/l and fibronectin level is > 3.2 mg/l, process activity is stated. EFFECT: increased determination accuracy. 1 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
AGENT FOR TREATMENT OF LIVER CIRRHOSIS ACCOMPANYING WITH ASCITIS | 2001 |
|
RU2224532C2 |
METHOD FOR TREATING THE CASES OF HEPATIC DISEASES | 2002 |
|
RU2217173C2 |
METHOD FOR INDIVIDUAL MATCHING MEDICINAL PREPARATIONS FOR TREATING PATIENTS WITH ETIOLOGICALLY DIFFERENT ACUTE AND CHRONIC VIRAL HEPATITIS | 2002 |
|
RU2222011C1 |
AGENT FOR TREATMENT OF CHRONIC PYELONEPHRITIS | 2001 |
|
RU2224531C2 |
METHOD FOR APPLYING PHYSIOTHERAPEUTIC LIVER TREATMENT | 2002 |
|
RU2232609C2 |
AGENT FOR TREATMENT OF UROLITHIASIS | 2005 |
|
RU2281781C1 |
METHOD FOR DETERMINING FUNCTIONAL RENAL RESERVE | 2006 |
|
RU2308725C1 |
METHOD FOR TREATING THE PATIENTS SUFFERING FROM HEMOCHROMATOSIS WITH INJURED LIVER | 2000 |
|
RU2185832C2 |
METHOD FOR DIAGNOSTICS OF DIABETIC NEPHROPATHY AT PRE-CLINICAL STAGE | 2007 |
|
RU2348038C1 |
METHOD FOR EVALUATING THE FUNCTIONAL STATE OF INTERNAL ORGANS | 2000 |
|
RU2195874C2 |
Authors
Dates
2003-10-20—Published
2002-01-21—Filed